Company intelligence / Profile preview

Scentryphar Clinical Research

Campinas, São Paulo, Brazil

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Scentryphar Clinical Research is a leading Brazilian Contract Research Organization (CRO) specializing in bioavailability and bioequivalence studies. Based in Campinas, the company provides a comprehensive suite of services including Phase I-IV clinical trials, pharmacokinetic analysis, and medical writing. In 2012, it was acquired by SGS, a global leader in inspection and certification, to strengthen its clinical research footprint in South America. The facility is recognized for its high-quality analytical laboratory and adherence to international regulatory standards. It was one of the first centers in Brazil to receive ANVISA certification for bioequivalence studies.

Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Beyond the preview

Go deeper on Scentryphar Clinical Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scentryphar Clinical Research.

Explore the full profile